{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:32:12Z","timestamp":1787020332912,"version":"build-2736575974"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Toronto 3D Knowledge Synthesis and Clinical Trials Foundation"},{"DOI":"10.13039\/501100000024","name":"Canadian Institute of Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003579","name":"University of Toronto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003579","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000023","name":"Government of Canada","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000023","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000241","name":"Physicians' Services Incorporated Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007476","name":"Canadian Diabetes Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007476","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015097","name":"Canadian Nutrition Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000064","name":"Banting and Best Diabetes Centre, University of Toronto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000064","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The Portfolio Diet is a plant-based dietary pattern of cholesterol-lowering foods that has demonstrated clinically meaningful reductions in low-density lipoprotein cholesterol (LDL-C) and other cardiovascular risk factors. However, the Portfolio Diet has not been assessed in an ethnoculturally diverse population of young adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To examine the association of the Portfolio Diet Score (PDS) with LDL-C and other established cardiovascular risk factors in a young adult population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional analysis included 1,507 men and women (mean age, 23\u2009\u00b1\u20093 years) of diverse ethnocultural backgrounds from the Toronto Nutrigenomics and Health Study. Diet was assessed by a validated Toronto-modified Harvard 196-item food frequency questionnaire with adherence to the Portfolio Diet measured using the Portfolio Diet Score. Data were analyzed using multiple linear regressions with adjustment for potential confounders. Modeling analyses related LDL-C levels according to absolute adherence to the Portfolio Diet with cumulative LDL-C and onset of rising cardiovascular risk by age.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Participants were Caucasian (49%), East Asian (34%), South Asian (11%), or other (7%) with a mean LDL-C of 2.3\u2009\u00b1\u20090.7mmol\/L. A 1-point higher PDS and higher PDS tertiles were associated with lower LDL-C (\u00df [95% CI] per 1-point: -0.009mmol\/L [-0.016, -0.002],\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.013; P\n                      <jats:sub>trend<\/jats:sub>\n                      across tertiles\u2009=0.040), non-HDL-C (-0.010mmol\/L [-0.018, -0.002],\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.014; P\n                      <jats:sub>trend<\/jats:sub>\n                      =0.028), total cholesterol (-0.011mmol\/L [-0.019, -0.003],\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.011; P\n                      <jats:sub>trend<\/jats:sub>\n                      =0.038), systolic blood pressure (-0.150mmHg [-0.250, -0.050],\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.003; P\n                      <jats:sub>trend<\/jats:sub>\n                      &lt;0.001) and diastolic blood pressure (-0.133mmHg [-0.219, -0.046],\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.003; P\n                      <jats:sub>trend<\/jats:sub>\n                      &lt;0.001). Higher PDS tertiles were associated with lower triglycerides (P\n                      <jats:sub>trend<\/jats:sub>\n                      =0.039). A 1-point higher PDS was also associated with lower BMI (-0.038 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      [-0.071, -0.004],\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.026), waist circumference (-0.092cm [-0.171, -0.013],\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.022), body weight (-0.124 kg [-0.229, -0.019],\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.021) and FMI (-0.019 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      [-0.037, -0.001],\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=0.039). There was no association with HDL-C, CRP, or fasting glucose. Modeling analyses suggest that compared to low adherence, 50% and 100% adherence to the Portfolio Diet may delay the onset of rising cardiovascular risk by an estimated 6 and 13 years, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Among young adults, the PDS was inversely associated with LDL-C and several other established cardiovascular risk factors. Early adherence to the Portfolio Diet may limit lifetime exposure to LDL-C and could delay the age at which cardiovascular events begin.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-025-22479-9","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T04:04:05Z","timestamp":1747109045000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Portfolio diet and LDL-C in a young, multiethnic cohort: cross-sectional analyses with cumulative exposure modeling"],"prefix":"10.1186","volume":"25","author":[{"given":"Victoria","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Chiavaroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea J.","family":"Glenn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meaghan E.","family":"Kavanagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Zeitoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Mahdavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril W. C.","family":"Kendall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J. A.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"El-Sohemy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Sievenpiper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"issue":"25","key":"22479_CR1","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982\u20133021.","journal-title":"J Am Coll Cardiol"},{"issue":"10053","key":"22479_CR2","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","volume":"388","author":"regional Global","year":"2016","unstructured":"Global regional. National life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1459\u2013544.","journal-title":"Lancet"},{"issue":"11","key":"22479_CR3","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1001\/jama.2023.2307","volume":"329","author":"R Aggarwal","year":"2023","unstructured":"Aggarwal R, Yeh RW, Joynt Maddox KE, Wadhera RK. Cardiovascular risk factor prevalence, treatment, and control in US adults aged 20 to 44 years, 2009 to March 2020. JAMA. 2023;329(11):899\u2013909.","journal-title":"JAMA"},{"issue":"11","key":"22479_CR4","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1001\/jama.2023.2308","volume":"329","author":"N Allen","year":"2023","unstructured":"Allen N, Wilkins JT. The urgent need to refocus cardiovascular disease prevention efforts on young adults. JAMA. 2023;329(11):886\u20137.","journal-title":"JAMA"},{"issue":"32","key":"22479_CR5","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","volume":"38","author":"BA Ference","year":"2017","unstructured":"Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European atherosclerosis society consensus panel. Eur Heart J. 2017;38(32):2459\u201372.","journal-title":"Eur Heart J"},{"issue":"12","key":"22479_CR6","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1001\/jama.2012.366","volume":"307","author":"SM Boekholdt","year":"2012","unstructured":"Boekholdt SM, Arsenault BJ, Mora S, Pedersen TR, LaRosa JC, Nestel PJ, et al. Association of LDL cholesterol, non-HDL cholesterol, and Apolipoprotein B levels with risk of cardiovascular events among patients treated with Statins: a meta-analysis. JAMA. 2012;307(12):1302\u20139.","journal-title":"JAMA"},{"issue":"12","key":"22479_CR7","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1001\/jamacardio.2021.3508","volume":"6","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Pletcher MJ, Vittinghoff E, Clemons AM, Jacobs DR Jr., Allen NB, et al. Association between cumulative Low-Density lipoprotein cholesterol exposure during young adulthood and middle age and risk of cardiovascular events. JAMA Cardiol. 2021;6(12):1406\u201313.","journal-title":"JAMA Cardiol"},{"issue":"5","key":"22479_CR8","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1161\/CIRCULATIONAHA.114.012477","volume":"131","author":"AM Navar-Boggan","year":"2015","unstructured":"Navar-Boggan AM, Peterson ED, D\u2019Agostino RB, Sr., Neely B, Sniderman AD, Pencina MJ. Hyperlipidemia in early adulthood increases long-term risk of coronary heart disease. Circulation. 2015;131(5):451\u20138.","journal-title":"Circulation"},{"issue":"25","key":"22479_CR9","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1016\/j.jacc.2012.09.017","volume":"60","author":"BA Ference","year":"2012","unstructured":"Ference BA, Yoo W, Alesh I, Mahajan N, Mirowska KK, Mewada A, et al. Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis. J Am Coll Cardiol. 2012;60(25):2631\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"22479_CR10","unstructured":"Canadian Cardiovascular Society. Framingham Risk Score (FRS). Estimation of 10-year Cardiovascular Disease (CVD) Risk 2017 [Available from: https:\/\/ccs.ca\/app\/uploads\/2020\/12\/FRS_eng_2017_fnl1.pdf"},{"key":"22479_CR11","doi-asserted-by":"publisher","first-page":"156084","DOI":"10.1016\/j.metabol.2024.156084","volume":"163","author":"F Fogacci","year":"2025","unstructured":"Fogacci F, Ray KK, Nicholls SJ, Cicero AFG. Reducing the global prevalence of cardiometabolic risk factors: a bet worth winning. Metabolism. 2025;163:156084.","journal-title":"Metabolism"},{"issue":"8","key":"22479_CR12","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.cjca.2021.03.016","volume":"37","author":"GJ Pearson","year":"2021","unstructured":"Pearson GJ, Thanassoulis G, Anderson TJ, Barry AR, Couture P, Dayan N, et al. 2021 Canadian cardiovascular society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults. Can J Cardiol. 2021;37(8):1129\u201350.","journal-title":"Can J Cardiol"},{"issue":"24","key":"22479_CR13","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1016\/j.jacc.2018.11.002","volume":"73","author":"SM Grundy","year":"2019","unstructured":"Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: executive summary: A report of the American college of cardiology\/american heart association task force on clinical practice guidelines. J Am Coll Cardiol. 2019;73(24):3168\u2013209.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"22479_CR14","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1001\/jama.290.4.502","volume":"290","author":"DJ Jenkins","year":"2003","unstructured":"Jenkins DJ, Kendall CW, Marchie A, Faulkner DA, Wong JM, de Souza R, et al. Effects of a dietary portfolio of cholesterol-lowering foods vs Lovastatin on serum lipids and C-reactive protein. JAMA. 2003;290(4):502\u201310.","journal-title":"JAMA"},{"issue":"8","key":"22479_CR15","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1001\/jama.2011.1202","volume":"306","author":"DJ Jenkins","year":"2011","unstructured":"Jenkins DJ, Jones PJ, Lamarche B, Kendall CW, Faulkner D, Cermakova L, et al. Effect of a dietary portfolio of cholesterol-lowering foods given at 2 levels of intensity of dietary advice on serum lipids in hyperlipidemia: a randomized controlled trial. JAMA. 2011;306(8):831\u20139.","journal-title":"JAMA"},{"issue":"12","key":"22479_CR16","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1053\/meta.2002.35578","volume":"51","author":"DJ Jenkins","year":"2002","unstructured":"Jenkins DJ, Kendall CW, Faulkner D, Vidgen E, Trautwein EA, Parker TL, et al. A dietary portfolio approach to cholesterol reduction: combined effects of plant sterols, vegetable proteins, and viscous fibers in hypercholesterolemia. Metabolism. 2002;51(12):1596\u2013604.","journal-title":"Metabolism"},{"issue":"18","key":"22479_CR17","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1503\/cmaj.092128","volume":"182","author":"DJ Jenkins","year":"2010","unstructured":"Jenkins DJ, Chiavaroli L, Wong JM, Kendall C, Lewis GF, Vidgen E, et al. Adding monounsaturated fatty acids to a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia. CMAJ. 2010;182(18):1961\u20137.","journal-title":"CMAJ"},{"key":"22479_CR18","unstructured":"Health Canada, Food Directorate Health Products and Food Branch. Plant Sterols and Blood Cholesterol Lowering 2010 [Available from: https:\/\/www.canada.ca\/en\/health-canada\/services\/food-nutrition\/food-labelling\/health-claims\/assessments\/plant-sterols-blood-cholesterol-lowering-nutrition-health-claims-food-labelling.html"},{"key":"22479_CR19","unstructured":"Health Canada, Food Directorate Health Products and Food Branch. Oat Products and Blood Cholesterol Lowering 2010 [Available from: https:\/\/www.canada.ca\/en\/health-canada\/services\/food-nutrition\/food-labelling\/health-claims\/assessments\/products-blood-cholesterol-lowering-summary-assessment-health-claim-about-products-blood-cholesterol-lowering.html"},{"key":"22479_CR20","unstructured":"Health Canada, Food Directorate Health Products and Food Branch. Summary of Health Canada\u2019s Assessment of a Health Claim about Food Products Containing Psyllium and Blood Cholesterol Lowering 2011 [Available from: https:\/\/www.canada.ca\/en\/health-canada\/services\/food-nutrition\/food-labelling\/health-claims\/assessments\/psyllium-products-blood-cholesterol-lowering-nutrition-health-claims-food-labelling.html"},{"key":"22479_CR21","unstructured":"Health Canada, Food Directorate Health Products and Food Branch. Summary of Health Canada\u2019s Assessment of a Health Claim about Soy Protein and Cholesterol Lowering 2015 [Available from: https:\/\/www.canada.ca\/en\/health-canada\/services\/food-nutrition\/food-labelling\/health-claims\/assessments\/summary-assessment-health-claim-about-protein-cholesterol-lowering.html"},{"key":"22479_CR22","unstructured":"US Food & Drug Administration. Qualified Health Claims: Letter of Enforcement Discretion - Nuts and Coronary Heart Disease (Docket No 02P-0505) 2003 [Available from: https:\/\/wayback.archive-it.org\/7993\/20171114183724\/https:\/\/www.fda.gov\/Food\/IngredientsPackagingLabeling\/LabelingNutrition\/ucm072926.htm"},{"key":"22479_CR23","unstructured":"US Food & Drug Administration. Food Labeling: Health Claims; Soluble Dietary Fiber From Certain Foods and Coronary Heart Disease 2005 [Available from: https:\/\/www.federalregister.gov\/documents\/2005\/12\/23\/05-24387\/food-labeling-health-claims-soluble-dietary-fiber-from-certain-foods-and-coronary-heart-disease#:~:text=SUMMARY%3A,of%20beta%2Dglucan%20soluble%20fiber"},{"key":"22479_CR24","doi-asserted-by":"publisher","unstructured":"EFSA Panel on Dietetic Products, Nutrion and Allergies. Scientific Opinion on the substantiation of a health claim related to oat beta glucan and lowering blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924\/2006 2010 [Available from: https:\/\/efsa.onlinelibrary.wiley.com\/doi\/abs\/https:\/\/doi.org\/10.2903\/j.efsa.2010.1885","DOI":"10.2903\/j.efsa.2010.1885"},{"key":"22479_CR25","doi-asserted-by":"publisher","unstructured":"EFSA Panel on Dietetic Products, Nutrion and Allergies. Scientific Opinion on the substantiation of a health claim related to 3\u00a0g\/day plant sterols\/stanols and lowering blood LDL-cholesterol and reduced risk of (coronary) heart disease pursuant to Article 19 of Regulation (EC) No 1924\/2006 2012 [Available from: https:\/\/efsa.onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.2903\/j.efsa.2012.2693","DOI":"10.2903\/j.efsa.2012.2693"},{"issue":"1","key":"22479_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.pcad.2018.05.004","volume":"61","author":"L Chiavaroli","year":"2018","unstructured":"Chiavaroli L, Nishi SK, Khan TA, Braunstein CR, Glenn AJ, Mejia SB, et al. Portfolio dietary pattern and cardiovascular disease: A systematic review and Meta-analysis of controlled trials. Prog Cardiovasc Dis. 2018;61(1):43\u201353.","journal-title":"Prog Cardiovasc Dis"},{"issue":"5","key":"22479_CR27","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1016\/j.clnu.2021.03.016","volume":"40","author":"AJ Glenn","year":"2021","unstructured":"Glenn AJ, Hern\u00e1ndez-Alonso P, Kendall CWC, Mart\u00ednez-Gonz\u00e1lez M, Corella D, Fit\u00f3 M, et al. Longitudinal changes in adherence to the portfolio and DASH dietary patterns and cardiometabolic risk factors in the PREDIMED-Plus study. Clin Nutr. 2021;40(5):2825\u201336.","journal-title":"Clin Nutr"},{"issue":"2","key":"22479_CR28","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3945\/ajcn.111.022657","volume":"95","author":"B Garc\u00eda-Bailo","year":"2012","unstructured":"Garc\u00eda-Bailo B, Brenner DR, Nielsen D, Lee HJ, Domanski D, Kuzyk M, et al. Dietary patterns and ethnicity are associated with distinct plasma proteomic groups. Am J Clin Nutr. 2012;95(2):352\u201361.","journal-title":"Am J Clin Nutr"},{"key":"22479_CR29","doi-asserted-by":"crossref","unstructured":"Nielsen DE, Boucher BA, Da Costa LA, Jenkins DJA, El-Sohemy A. Reproducibility and validity of the Toronto-modified Harvard food frequency questionnaire in a multi-ethnic sample of young adults. Eur J Clin Nutr. 2022.","DOI":"10.1038\/s41430-022-01209-z"},{"key":"22479_CR30","doi-asserted-by":"crossref","unstructured":"Glenn AJ, Boucher BA, Kavcic CC, Khan TA, Paquette M, Kendall CWC et al. Development of a portfolio diet score and its concurrent and predictive validity assessed by a food frequency questionnaire. Nutrients. 2021;13(8).","DOI":"10.3390\/nu13082850"},{"issue":"4","key":"22479_CR31","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1093\/aje\/kwp156","volume":"170","author":"L Cahill","year":"2009","unstructured":"Cahill L, Corey PN, El-Sohemy A. Vitamin C deficiency in a population of young Canadian adults. Am J Epidemiol. 2009;170(4):464\u201371.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"22479_CR32","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1001\/jamacardio.2020.0013","volume":"5","author":"M Sampson","year":"2020","unstructured":"Sampson M, Ling C, Sun Q, Harb R, Ashmaig M, Warnick R, et al. A new equation for calculation of Low-Density lipoprotein cholesterol in patients with normolipidemia and\/or hypertriglyceridemia. JAMA Cardiol. 2020;5(5):540\u20138.","journal-title":"JAMA Cardiol"},{"key":"22479_CR33","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ijcard.2021.02.009","volume":"330","author":"F Piani","year":"2021","unstructured":"Piani F, Cicero AFG, Ventura F, Dormi A, Fogacci F, Patrono D, et al. Evaluation of twelve formulas for LDL-C Estimation in a large, blinded, random Italian population. Int J Cardiol. 2021;330:221\u20137.","journal-title":"Int J Cardiol"},{"issue":"8","key":"22479_CR34","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.cjca.2022.03.019","volume":"38","author":"NMA White-Al Habeeb","year":"2022","unstructured":"White-Al Habeeb NMA, Higgins V, Venner AA, Bailey D, Beriault DR, Collier C, et al. Canadian society of clinical chemists harmonized clinical laboratory lipid reporting recommendations on the basis of the 2021 Canadian cardiovascular society lipid guidelines. Can J Cardiol. 2022;38(8):1180\u20138.","journal-title":"Can J Cardiol"},{"issue":"19","key":"22479_CR35","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1001\/jama.2013.280532","volume":"310","author":"SS Martin","year":"2013","unstructured":"Martin SS, Blaha MJ, Elshazly MB, Toth PP, Kwiterovich PO, Blumenthal RS, et al. Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile. JAMA. 2013;310(19):2061\u20138.","journal-title":"JAMA"},{"key":"22479_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1476-511X-9-27","volume":"9","author":"A Vujovic","year":"2010","unstructured":"Vujovic A, Kotur-Stevuljevic J, Spasic S, Bujisic N, Martinovic J, Vujovic M, et al. Evaluation of different formulas for LDL-C calculation. Lipids Health Dis. 2010;9:27.","journal-title":"Lipids Health Dis"},{"issue":"2","key":"22479_CR37","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1079\/BJN19910073","volume":"65","author":"P Deurenberg","year":"1991","unstructured":"Deurenberg P, Weststrate JA, Seidell JC. Body mass index as a measure of body fatness: age- and sex-specific prediction formulas. Br J Nutr. 1991;65(2):105\u201314.","journal-title":"Br J Nutr"},{"issue":"10","key":"22479_CR38","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.jacc.2018.06.046","volume":"72","author":"BA Ference","year":"2018","unstructured":"Ference BA, Graham I, Tokgozoglu L, Catapano AL. Impact of lipids on cardiovascular health: JACC health promotion series. J Am Coll Cardiol. 2018;72(10):1141\u201356.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"22479_CR39","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1093\/ajcn.83.3.582","volume":"83","author":"DJ Jenkins","year":"2006","unstructured":"Jenkins DJ, Kendall CW, Faulkner DA, Nguyen T, Kemp T, Marchie A, et al. Assessment of the longer-term effects of a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia. Am J Clin Nutr. 2006;83(3):582\u201391.","journal-title":"Am J Clin Nutr"},{"issue":"11","key":"22479_CR40","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/S0026-0495(03)00260-9","volume":"52","author":"DJ Jenkins","year":"2003","unstructured":"Jenkins DJ, Kendall CW, Marchie A, Faulkner D, Vidgen E, Lapsley KG, et al. The effect of combining plant sterols, soy protein, viscous fibers, and almonds in treating hypercholesterolemia. Metabolism. 2003;52(11):1478\u201383.","journal-title":"Metabolism"},{"key":"22479_CR41","doi-asserted-by":"crossref","unstructured":"Kavanagh ME, Glenn AJ, Chiavaroli L, Morgan GA, Josse RG, Malik VS et al. Simulation model to assess the validity of the clinical portfolio diet score used in the PortfolioDiet.app for dietary self-tracking: a secondary analysis of a randomized controlled trial in hyperlipidemic adults. Front Nutr. 2024;11.","DOI":"10.3389\/fnut.2024.1398450"},{"issue":"22","key":"22479_CR42","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1161\/CIRCULATIONAHA.123.065551","volume":"148","author":"AJ Glenn","year":"2023","unstructured":"Glenn AJ, Guasch-Ferr\u00e9 M, Malik VS, Kendall CWC, Manson JE, Rimm EB, et al. Portfolio diet score and risk of cardiovascular disease: findings from 3 prospective cohort studies. Circulation. 2023;148(22):1750\u201363.","journal-title":"Circulation"},{"issue":"4","key":"22479_CR43","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1089\/jmf.2017.3976","volume":"21","author":"Y Liu","year":"2018","unstructured":"Liu Y, Hwang HJ, Kim HS, Park H. Time and intervention effects of daily almond intake on the changes of lipid profile and body composition among Free-Living healthy adults. J Med Food. 2018;21(4):340\u20137.","journal-title":"J Med Food"},{"key":"22479_CR44","doi-asserted-by":"crossref","unstructured":"Sumislawski K, Widmer A, Suro RR, Robles ME, Lillegard K, Olson D et al. Consumption of tree nuts as snacks reduces metabolic syndrome risk in young adults: A randomized trial. Nutrients. 2023;15(24).","DOI":"10.3390\/nu15245051"},{"issue":"6","key":"22479_CR45","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1093\/ajcn\/71.6.1462","volume":"71","author":"BE Merz-Demlow","year":"2000","unstructured":"Merz-Demlow BE, Duncan AM, Wangen KE, Xu X, Carr TP, Phipps WR, et al. Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women. Am J Clin Nutr. 2000;71(6):1462\u20139.","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"22479_CR46","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/ajcn\/83.2.244","volume":"83","author":"BL McVeigh","year":"2006","unstructured":"McVeigh BL, Dillingham BL, Lampe JW, Duncan AM. Effect of soy protein varying in isoflavone content on serum lipids in healthy young men. Am J Clin Nutr. 2006;83(2):244\u201351.","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"22479_CR47","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/ejcn.2011.102","volume":"65","author":"M Kristensen","year":"2011","unstructured":"Kristensen M, B\u00fcgel S. A diet rich in oat Bran improves blood lipids and hemostatic factors, and reduces apparent energy digestibility in young healthy volunteers. Eur J Clin Nutr. 2011;65(9):1053\u20138.","journal-title":"Eur J Clin Nutr"},{"issue":"10","key":"22479_CR48","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/sj.ejcn.1601234","volume":"55","author":"L Hodson","year":"2001","unstructured":"Hodson L, Skeaff CM, Chisholm WA. The effect of replacing dietary saturated fat with polyunsaturated or monounsaturated fat on plasma lipids in free-living young adults. Eur J Clin Nutr. 2001;55(10):908\u201315.","journal-title":"Eur J Clin Nutr"},{"issue":"3","key":"22479_CR49","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1079\/BJN2003953","volume":"90","author":"RD Smith","year":"2003","unstructured":"Smith RD, Kelly CN, Fielding BA, Hauton D, Silva KD, Nydahl MC, et al. Long-term monounsaturated fatty acid diets reduce platelet aggregation in healthy young subjects. Br J Nutr. 2003;90(3):597\u2013606.","journal-title":"Br J Nutr"},{"key":"22479_CR50","doi-asserted-by":"crossref","unstructured":"Navarro-Prado S, Schmidt-RioValle J, Montero-Alonso MA, Fern\u00e1ndez-Aparicio \u00c1, Gonz\u00e1lez-Jim\u00e9nez E. Stricter adherence to dietary approaches to stop hypertension (DASH) and its association with lower blood pressure, visceral fat, and waist circumference in university students. Nutrients. 2020;12(3).","DOI":"10.3390\/nu12030740"},{"key":"22479_CR51","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.nutres.2022.07.008","volume":"106","author":"AJ Lobene","year":"2022","unstructured":"Lobene AJ, Smiljanec K, Axler MR, Ramos-Gonzalez M, Lennon SL. Greater adherence to healthy dietary patterns is associated with lower diastolic blood pressure and augmentation index in healthy, young adults. Nutr Res. 2022;106:60\u201371.","journal-title":"Nutr Res"},{"key":"22479_CR52","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.eujim.2017.07.003","volume":"13","author":"L \u0160tefan","year":"2017","unstructured":"\u0160tefan L, \u010cule M, Milinovi\u0107 I, Spori\u0161 G, Juranko D. The relationship between adherence to the mediterranean diet and body composition in Croatian university students. Eur J Integr Med. 2017;13:41\u20136.","journal-title":"Eur J Integr Med"},{"key":"22479_CR53","doi-asserted-by":"crossref","unstructured":"Lopes S, Fontes T, Menezes R, Rodrigues LM, Ferreira-P\u00eago C. Mediterranean diet adherence and its relationship to metabolic markers and body composition in Portuguese university students. Nutrients. 2023;15(10).","DOI":"10.3390\/nu15102330"},{"issue":"4","key":"22479_CR54","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.amjmed.2020.08.012","volume":"134","author":"VW Zhong","year":"2021","unstructured":"Zhong VW, Ning H, Van Horn L, Carnethon MR, Wilkins JT, Lloyd-Jones DM, et al. Diet quality and Long-Term absolute risks for incident cardiovascular disease and mortality. Am J Med. 2021;134(4):490\u2013e824.","journal-title":"Am J Med"},{"issue":"10","key":"22479_CR55","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1017\/S0007114514002633","volume":"112","author":"LM Steffen","year":"2014","unstructured":"Steffen LM, Van Horn L, Daviglus ML, Zhou X, Reis JP, Loria CM, et al. A modified mediterranean diet score is associated with a lower risk of incident metabolic syndrome over 25 years among young adults: the CARDIA (Coronary artery risk development in young Adults) study. Br J Nutr. 2014;112(10):1654\u201361.","journal-title":"Br J Nutr"},{"issue":"1","key":"22479_CR56","doi-asserted-by":"publisher","first-page":"28","DOI":"10.2337\/dc22-1029","volume":"46","author":"AJ Glenn","year":"2023","unstructured":"Glenn AJ, Li J, Lo K, Jenkins DJA, Boucher BA, Hanley AJ, et al. The portfolio diet and incident type 2 diabetes: findings from the women\u2019s health initiative prospective cohort study. Diabetes Care. 2023;46(1):28\u201337.","journal-title":"Diabetes Care"},{"issue":"16","key":"22479_CR57","doi-asserted-by":"publisher","first-page":"e021515","DOI":"10.1161\/JAHA.121.021515","volume":"10","author":"AJ Glenn","year":"2021","unstructured":"Glenn AJ, Lo K, Jenkins DJA, Boucher BA, Hanley AJ, Kendall CWC, et al. Relationship between a Plant-Based dietary portfolio and risk of cardiovascular disease: findings from the women\u2019s health initiative prospective cohort study. J Am Heart Assoc. 2021;10(16):e021515.","journal-title":"J Am Heart Assoc"},{"key":"22479_CR58","doi-asserted-by":"crossref","unstructured":"Lo K, Glenn AJ, Yeung S, Kendall CWC, Sievenpiper JL, Jenkins DJA et al. Prospective association of the portfolio diet with All-Cause and Cause-Specific mortality risk in the Mr. OS and Ms. OS Study Nutrients. 2021;13(12).","DOI":"10.3390\/nu13124360"},{"issue":"4","key":"22479_CR59","doi-asserted-by":"publisher","first-page":"596","DOI":"10.2337\/dc14-1986","volume":"38","author":"JJ Rhee","year":"2015","unstructured":"Rhee JJ, Mattei J, Hughes MD, Hu FB, Willett WC. Dietary diabetes risk reduction score, race and ethnicity, and risk of type 2 diabetes in women. Diabetes Care. 2015;38(4):596\u2013603.","journal-title":"Diabetes Care"},{"issue":"8","key":"22479_CR60","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1017\/S0007114511006969","volume":"108","author":"A B\u00e9dard","year":"2012","unstructured":"B\u00e9dard A, Riverin M, Dodin S, Corneau L, Lemieux S. Sex differences in the impact of the mediterranean diet on cardiovascular risk profile. Br J Nutr. 2012;108(8):1428\u201334.","journal-title":"Br J Nutr"},{"key":"22479_CR61","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1475-2891-13-107","volume":"13","author":"V Leblanc","year":"2014","unstructured":"Leblanc V, B\u00e9gin C, Hudon AM, Royer MM, Corneau L, Dodin S, et al. Gender differences in the long-term effects of a nutritional intervention program promoting the mediterranean diet: changes in dietary intakes, eating behaviors, anthropometric and metabolic variables. Nutr J. 2014;13:107.","journal-title":"Nutr J"},{"issue":"1","key":"22479_CR62","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/aje\/kwg091","volume":"158","author":"V Kipnis","year":"2003","unstructured":"Kipnis V, Subar AF, Midthune D, Freedman LS, Ballard-Barbash R, Troiano RP, et al. Structure of dietary measurement error: results of the OPEN biomarker study. Am J Epidemiol. 2003;158(1):14\u201321. discussion 2\u20136.","journal-title":"Am J Epidemiol"},{"issue":"11","key":"22479_CR63","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.jacc.2024.05.070","volume":"84","author":"JT Wilkins","year":"2024","unstructured":"Wilkins JT, Ning H, Allen NB, Zheutlin A, Shah NS, Feinstein MJ, et al. Prediction of cumulative exposure to atherogenic lipids during early adulthood. J Am Coll Cardiol. 2024;84(11):961\u201373.","journal-title":"J Am Coll Cardiol"},{"key":"22479_CR64","doi-asserted-by":"publisher","first-page":"n1651","DOI":"10.1136\/bmj.n1651","volume":"374","author":"L Chiavaroli","year":"2021","unstructured":"Chiavaroli L, Lee D, Ahmed A, Cheung A, Khan TA, Blanco S, et al. Effect of low glycaemic index or load dietary patterns on glycaemic control and cardiometabolic risk factors in diabetes: systematic review and meta-analysis of randomised controlled trials. BMJ. 2021;374:n1651.","journal-title":"BMJ"},{"issue":"1","key":"22479_CR65","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.amjcard.2009.08.651","volume":"105","author":"SJ Nicholls","year":"2010","unstructured":"Nicholls SJ, Brandrup-Wognsen G, Palmer M, Barter PJ. Meta-analysis of comparative efficacy of increasing dose of Atorvastatin versus Rosuvastatin versus Simvastatin on Lowering levels of atherogenic lipids (from VOYAGER). Am J Cardiol. 2010;105(1):69\u201376.","journal-title":"Am J Cardiol"},{"issue":"19","key":"22479_CR66","doi-asserted-by":"publisher","first-page":"e016115","DOI":"10.1161\/JAHA.120.016115","volume":"9","author":"HC Gooding","year":"2020","unstructured":"Gooding HC, Gidding SS, Moran AE, Redmond N, Allen NB, Bacha F, et al. Challenges and opportunities for the prevention and treatment of cardiovascular disease among young adults: report from a National heart, lung, and blood Institute working group. J Am Heart Assoc. 2020;9(19):e016115.","journal-title":"J Am Heart Assoc"},{"issue":"15","key":"22479_CR67","doi-asserted-by":"publisher","first-page":"e233","DOI":"10.1161\/CIRCULATIONAHA.121.057125","volume":"144","author":"DM Lloyd-Jones","year":"2021","unstructured":"Lloyd-Jones DM, Albert MA, Elkind M. The American heart association\u2019s focus on primordial prevention. Circulation. 2021;144(15):e233\u20135.","journal-title":"Circulation"},{"issue":"24","key":"22479_CR68","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1016\/j.jacc.2017.10.024","volume":"70","author":"L Fern\u00e1ndez-Friera","year":"2017","unstructured":"Fern\u00e1ndez-Friera L, Fuster V, L\u00f3pez-Melgar B, Oliva B, Garc\u00eda-Ruiz JM, Mendiguren J, et al. Normal LDL-Cholesterol levels are associated with subclinical atherosclerosis in the absence of risk factors. J Am Coll Cardiol. 2017;70(24):2979\u201391.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"22479_CR69","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12966-018-0719-8","volume":"15","author":"EM Winpenny","year":"2018","unstructured":"Winpenny EM, van Sluijs EMF, White M, Klepp KI, Wold B, Lien N. Changes in diet through adolescence and early adulthood: longitudinal trajectories and association with key life transitions. Int J Behav Nutr Phys Act. 2018;15(1):86.","journal-title":"Int J Behav Nutr Phys Act"},{"issue":"12","key":"22479_CR70","doi-asserted-by":"publisher","first-page":"e863","DOI":"10.1016\/S2542-5196(21)00278-3","volume":"5","author":"C Hickman","year":"2021","unstructured":"Hickman C, Marks E, Pihkala P, Clayton S, Lewandowski RE, Mayall EE, et al. Climate anxiety in children and young people and their beliefs about government responses to climate change: a global survey. Lancet Planet Health. 2021;5(12):e863\u201373.","journal-title":"Lancet Planet Health"},{"issue":"5","key":"22479_CR71","doi-asserted-by":"publisher","first-page":"e97480","DOI":"10.1371\/journal.pone.0097480","volume":"9","author":"EA Korkala","year":"2014","unstructured":"Korkala EA, Hugg TT, Jaakkola JJ. Awareness of climate change and the dietary choices of young adults in Finland: a population-based cross-sectional study. PLoS ONE. 2014;9(5):e97480.","journal-title":"PLoS ONE"},{"key":"22479_CR72","doi-asserted-by":"publisher","first-page":"100041","DOI":"10.1016\/j.clrc.2021.100041","volume":"3","author":"K J\u00fcrkenbeck","year":"2021","unstructured":"J\u00fcrkenbeck K, Spiller A, Schulze M. Climate change awareness of the young generation and its impact on their diet. Clean Responsible Consum. 2021;3:100041.","journal-title":"Clean Responsible Consum"},{"issue":"33","key":"22479_CR73","doi-asserted-by":"publisher","first-page":"e2120584119","DOI":"10.1073\/pnas.2120584119","volume":"119","author":"M Clark","year":"2022","unstructured":"Clark M, Springmann M, Rayner M, Scarborough P, Hill J, Tilman D, et al. Estimating the environmental impacts of 57,000 food products. Proc Natl Acad Sci U S A. 2022;119(33):e2120584119.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"22479_CR74","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/j.1467-789X.2011.00863.x","volume":"12","author":"FB Hu","year":"2011","unstructured":"Hu FB, Liu Y, Willett WC. Preventing chronic diseases by promoting healthy diet and lifestyle: public policy implications for China. Obes Rev. 2011;12(7):552\u20139.","journal-title":"Obes Rev"},{"issue":"22","key":"22479_CR75","doi-asserted-by":"crossref","first-page":"e505","DOI":"10.1161\/CIR.0000000000000462","volume":"134","author":"L Van Horn","year":"2016","unstructured":"Van Horn L, Carson JA, Appel LJ, Burke LE, Economos C, Karmally W, et al. Recommended dietary pattern to achieve adherence to the American heart association\/american college of cardiology (AHA\/ACC) guidelines: A scientific statement from the American heart association. Circulation. 2016;134(22):e505\u201329.","journal-title":"Circulation"},{"issue":"4","key":"22479_CR76","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1017\/S0007114508073649","volume":"101","author":"A Misra","year":"2009","unstructured":"Misra A, Khurana L, Isharwal S, Bhardwaj S. South Asian diets and insulin resistance. Br J Nutr. 2009;101(4):465\u201373.","journal-title":"Br J Nutr"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-22479-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-22479-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-22479-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T05:04:43Z","timestamp":1747112683000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-22479-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22479"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-22479-9","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,13]]},"assertion":[{"value":"20 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. The study protocol was approved by the Research Ethics Board at the University of Toronto and written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"LC has received research support from the Canadian Institutes of Health Research (CIHR), Protein Industries Canada (a Government of Canada Global Innovation Clusters), The United Soybean Board (USDA soy \u201cCheckoff\u201d program), and the Alberta Pulse Growers Association. AJG has received honoraria or travel support from the British Nutrition Society, Vinasoy, and the Good Food Institute. SM has received funding for advisory board activities, consulting roles, educational grants, travel grants, and speaker\/moderator honoraria from the American Academy of Nutrition, World Congress of Aesthetics and Anti-Aging Medicine, Canadian Board of Aesthetic Medicine, Canadian Association of Medical Aesthetics, Canadian Association of Aesthetic Medicine, Los Angeles Multi-Specialty Cosmetic Academy, Allergan, Galderma, Sanofi, Shire, Genzyme, Gambro, Nutrigenomix, and Abbott. SM has received fellowship, educational, and research funding from Harvard University, the University of Toronto, and Mitacs. SM has provided in-kind educational speaker services to the University of Miami Dermatology Department and has served on the Editorial Board of the Canadian Journal of Kidney Disease and Health, the official journal of the Canadian Society of Nephrology. SM is an associate editor of the Canadian Journal of Kidney Disease and Health and an assistant editor of BMJ Nutrition, Prevention & Health. CWCK has received grants or research support from the Advanced Food Materials Network, Agriculture and Agri-Foods Canada (AAFC), Almond Board of California, Barilla, Canadian Institutes of Health Research (CIHR), Canola Council of Canada, International Nut and Dried Fruit Council, International Tree Nut Council Research and Education Foundation, Loblaw Brands Ltd, the Peanut Institute, Pulse Canada and Unilever. He has received in-kind research support from the Almond Board of California, Barilla, California Walnut Commission, Kellogg Canada, Loblaw Companies, Nutrartis, Quaker (PepsiCo), the Peanut Institute, Primo, Unico, Unilever, WhiteWave Foods\/Danone. He has received travel support and\/or honoraria from the Barilla, California Walnut Commission, Canola Council of Canada, General Mills, International Nut and Dried Fruit Council, International Pasta Organization, Lantmannen, Loblaw Brands Ltd, Nutrition Foundation of Italy, Oldways Preservation Trust, Paramount Farms, the Peanut Institute, Pulse Canada, Sun-Maid, Tate & Lyle, Unilever and White Wave Foods\/Danone. He has served on the scientific advisory board for the International Tree Nut Council, International Pasta Organization, McCormick Science Institute and Oldways Preservation Trust. He is a founding member of the International Carbohydrate Quality Consortium (ICQC), Executive Board Member of the Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD), is on the Clinical Practice Guidelines Expert Committee for Nutrition Therapy of the EASD and is a Director of the Toronto 3D Knowledge Synthesis and Clinical Trials foundation. DJAJ has received research grants from Loblaw Companies Ltd., the Almond Board of California, Soy Nutrition Institute (SNI), and the Canadian Institutes of Health Research (CIHR). He has received in-kind supplies for trials as a research support from the Almond board of California, Walnut Council of California, American Peanut Council, Barilla, Unilever, Unico, Primo, Loblaw Companies, Quaker (Pepsico), Pristine Gourmet, Bunge Limited, Kellogg Canada, WhiteWave Foods. He has been on the speaker\u2019s panel, served on the scientific advisory board and\/or received travel support and\/or honoraria from the Lawson Centre Nutrition Digital Series, 19th Annual Stare-Hegsted Lecture, 2024 Diabetes Canada Conference, Nutritional Fundamentals for Health (NFH)-Nutramedica, Saint Barnabas Medical Center, The University of Chicago, 2020 China Glycemic Index (GI) International Conference, Atlantic Pain Conference, Academy of Life Long Learning, the Almond Board of California, Canadian Agriculture Policy Institute, the Loblaw Companies Ltd, the Griffin Hospital (for the development of the NuVal scoring system), the Coca-Cola Company, Epicure, Danone, Diet Quality Photo Navigation (DQPN), Better Therapeutics (FareWell), Verywell, True Health Initiative (THI), Heali AI Corp, Institute of Food Technologists (IFT), Soy Nutrition Institute (SNI), Herbalife Nutrition Institute (HNI), Herbalife International, Pacific Health Laboratories, Nutritional Fundamentals for Health (NFH), the Soy Foods Association of North America, the Nutrition Foundation of Italy (NFI), the Toronto Knowledge Translation Group (St. Michael\u2019s Hospital), the Canadian College of Naturopathic Medicine, The Hospital for Sick Children, the Canadian Nutrition Society (CNS), and the American Society of Nutrition (ASN). He is a member of the International Carbohydrate Quality Consortium (ICQC). His wife, Alexandra L Jenkins, is senior scientist of INQUIS Clinical Research Inc. (Clinical Research Organization), his 2 daughters, Wendy Jenkins and Amy Jenkins, have published a vegetarian book that promotes the use of the low glycemic index plant foods advocated here, The Portfolio Diet for Cardiovascular Risk Reduction (Academic Press\/Elsevier 2020 ISBN:978-0-12-810510-8) and his sister, Caroline Brydson, received funding through a grant from the St. Michael\u2019s Hospital Foundation to develop a cookbook for one of his studies. AE-S is the founder and holds shares in Nutrigenomix Inc. JLS has received research support from the Canadian Foundation for Innovation, Ontario Research Fund, Province of Ontario Ministry of Research and Innovation and Science, Canadian Institutes of health Research (CIHR), Diabetes Canada, American Society for Nutrition (ASN), National Honey Board (U.S. Department of Agriculture [USDA] honey \u201cCheckoff\u201d program), Institute for the Advancement of Food and Nutrition Sciences (IAFNS), Pulse Canada, Quaker Oats Center of Excellence, INC International Nut and Dried Fruit Council Foundation, The United Soybean Board (USDA soy \u201cCheckoff\u201d program), Protein Industries Canada (a Government of Canada Global Innovation Cluster), Almond Board of California, European Fruit Juice Association, The Tate and Lyle Nutritional Research Fund at the University of Toronto, The Glycemic Control and Cardiovascular Disease in Type 2 Diabetes Fund at the University of Toronto (a fund established by the Alberta Pulse Growers), The Plant Protein Fund at the University of Toronto (a fund which has received contributions from IFF among other donors), The Plant Milk Fund at the University of Toronto (a fund established by the Karuna Foundation through Vegan Grants), and The Nutrition Trialists Network Fund at the University of Toronto (a fund established by donations from the Calorie Control Council, Physicians Committee for Responsible Medicine, and Login5 Foundation). He has received food donations to support randomized controlled trials from the Almond Board of California, California Walnut Commission, Danone, Nutrartis, Soylent, and Dairy Farmers of Canada. He has received travel support, speaker fees and\/or honoraria from FoodMinds LLC, Nestl\u00e9, Abbott, General Mills, Nutrition Communications, International Food Information Council (IFIC), Arab Beverage Association, International Sweeteners Association, Calorie Control Council, Phynova, and Collaborative CME and Research Network (CCRN). He has or has had ad hoc consulting arrangements with Almond Board of California, Perkins Coie LLP, Tate & Lyle, Ingredion, and Brightseed. He is on the Clinical Practice Guidelines Expert Committees of Diabetes Canada, European Association for the study of Diabetes (EASD), Canadian Cardiovascular Society (CCS), and Obesity Canada\/Canadian Association of Bariatric Physicians and Surgeons. He serves as an unpaid member of the Board of Trustees of IAFNS. He is a Director at Large of the Canadian Nutrition Society (CNS), founding member of the International Carbohydrate Quality Consortium (ICQC), Executive Board Member of the Diabetes and Nutrition Study Group (DNSG) of the EASD, and Director of the Toronto 3D Knowledge Synthesis and Clinical Trials foundation. His spouse is a former employee of Nestle Health Science and AB InBev. VC, MEK and TZ report no relevant competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1761"}}